Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 AUD | +2.04% | -8.26% | -24.81% |
Apr. 19 | INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test | MT |
Apr. 15 | Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares | MT |
Sales 2024 * | 900K 600K | Sales 2025 * | 1.6M 1.07M | Capitalization | 45.09M 30.08M |
---|---|---|---|---|---|
Net income 2024 * | -9M -6M | Net income 2025 * | -8M -5.34M | EV / Sales 2024 * | 42.2 x |
Net cash position 2024 * | 7.1M 4.74M | Net cash position 2025 * | 8.9M 5.94M | EV / Sales 2025 * | 22.6 x |
P/E ratio 2024 * |
-5
x | P/E ratio 2025 * |
-6.53
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.68% |
1 day | +2.04% | ||
1 week | -8.26% | ||
1 month | -5.66% | ||
3 months | -24.24% | ||
6 months | -16.67% | ||
Current year | -24.81% |
Managers | Title | Age | Since |
---|---|---|---|
Leearne Hinch
CEO | Chief Executive Officer | - | 16-11-06 |
Mark Edwards
DFI | Director of Finance/CFO | - | 22-11-01 |
Gregory Rice
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | Nov. 28 | |
Philip Powell
BRD | Director/Board Member | 65 | 19-06-17 |
Geoff Cumming
BRD | Director/Board Member | - | 20-07-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 0.5 | +2.04% | 73 133 |
24-05-20 | 0.49 | -3.92% | 82,606 |
24-05-17 | 0.51 | +2.00% | 20,545 |
24-05-16 | 0.5 | -3.85% | 56,620 |
24-05-15 | 0.52 | -4.59% | 16,445 |
Delayed Quote Australian S.E., May 21, 2024 at 01:55 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.81% | 30.11M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+47.19% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- IIQ Stock